Home
>
National Drug Code (NDC)
>
Liothyronine Sodium
Liothyronine Sodium - 39822-0151-1 - (Liothyronine Sodium Injection)
Drug Information of Liothyronine Sodium
| Product NDC: | 39822-0151 |
| Proprietary Name: | Liothyronine Sodium |
| Non Proprietary Name: | Liothyronine Sodium Injection |
| Active Ingredient(s): | 10 ug/mL & nbsp; Liothyronine Sodium Injection |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Liothyronine Sodium
| Product NDC: | 39822-0151 |
| Labeler Name: | X-GEN Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076923 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050817 |
Package Information of Liothyronine Sodium
| Package NDC: | 39822-0151-1 |
| Package Description: | 1 VIAL in 1 CARTON (39822-0151-1) > 1 mL in 1 VIAL |
NDC Information of Liothyronine Sodium
| NDC Code | 39822-0151-1 |
| Proprietary Name | Liothyronine Sodium |
| Package Description | 1 VIAL in 1 CARTON (39822-0151-1) > 1 mL in 1 VIAL |
| Product NDC | 39822-0151 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Liothyronine Sodium Injection |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050817 |
| Marketing Category Name | ANDA |
| Labeler Name | X-GEN Pharmaceuticals, Inc. |
| Substance Name | LIOTHYRONINE SODIUM |
| Strength Number | 10 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
